![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Addis A, Koren G. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychology in Medicine 2000; 30: 89–94
- Alves S E, Akbari H M, Anderson G M, Azmitia E C, McEwan B C, Strand F L. Neonatal ACTH administration elicits long term changes in forebrain monoamine innervation: subsequent disruptions in hypothalamic-pituitary-adrenal and gonadal function. Annals of the New York Academy of Science 1997; 814: 226–251
- Chambers C, Johnson K, Dick L, Felix R R, Jones K L. Birth outcomes in pregnant women taking fluoxetine. New England Journal of Medicine 1996; 335: 1010–1015
- Glover V. Maternal stress or anxiety in pregnancy and emotional development of the child. British Journal of Psychiatry 1997; 171: 105–106
- Goldberg H L. Psychotropic drugs in pregnancy and lactation. International Journal of Psychiatry in Medicine 1994; 24: 129–147
- Isbister G K, Dawson A, Whyte I M, Prior F H, Clancy C, Smith A J. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?. Archives of Diseases in Childhood. Fetal and Neonatal Edition 2001; 85: 147–148
- McElhatton P. Use of antidepressants in pregnancy and lactation. Prescriber 1999; 108: 101–104
- Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. International Journal of Psychiatric Medicine 1991; 21: 157–171
- Murray L. The impact of postnatal depression on infant development. Journal of Child Psychology and Psychiatry 1992; 33: 543–561
- Murray L, Cooper P. Effects of postnatal depression on infant development. Archives of Diseases in Childhood 1997; 77: 99–101
- Nonacs R, Cohen L S. Depression during pregnancy: diagnosis and treatment options. Journal of Clinical Psychiatry 2002; 63: 24–30
- O'Hara M W. Social support, life events and depression during pregnancy and the puerperium. Archives of General Psychiatry 1986; 43: 569–573
- Orr S T, Millar C A. Maternal depressive symptoms and the risks of poor pregnancy outcome: review of literature and preliminary findings. Epidemiological Review 1995; 17: 165–171
- Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, et al. Pregnancy outcome following first trimester exposure to fluoxetine. Journal of the American Medical Association 1993; 269: 2246–2248
- Teixeira J M, Fisk N M, Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. British Medical Journal 1999; 318: 153–157
- Toxbase fact sheet. Fluoxetine in pregnancy. National Teratology Information Service. 1999, June
- Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, et al. Neurotoxicity of glucocorticoids in the primate brain. Hormonal Behaviour 1994; 28: 336–348
- Weinberg M, Tronick E. The impact of maternal psychiatric illness on infant development. Journal of Clinical Psychiatry 1998; 59: 53–61
- Young S A, Campbell N, Harper A. Depression in women of reproductive age. Postgraduate Medicine 2002; 112: 45–50
- Zuckerman B, Amaro H, Bauchner H, Cabral H. Depressive symptoms during pregnancy: relationship to poor health behaviours. American Journal of Obstetrics and Gynecology 1989; 160: 1107–1111